Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Panic Disorder

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Panic Disorder in 8 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Panic Disorder: A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait.

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (75.00)18.2507
2000's1 (12.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaplan, K1
Kurtz, F1
Serafini, K1
Soar, K1
Parrott, AC1
Fox, HC1
McGuire, PK1
Cope, H1
Fahy, TA1
Windhaber, J1
Maierhofer, D1
Dantendorfer, K1
Kuntze, MF1
Pennings, EJ1
Konijn, KZ1
de Wolff, FA1
Pallanti, S1
Mazzi, D1
McCann, UD1
Ricaurte, GA1

Reviews

1 review available for n-methyl-3,4-methylenedioxyamphetamine and Panic Disorder

ArticleYear
[Clinical and toxicologic aspects of the use of Ecstasy].
    Nederlands tijdschrift voor geneeskunde, 1998, Aug-29, Volume: 142, Issue:35

    Topics: Animals; Axons; Brain Chemistry; Depression; Female; Fever; Humans; Impulsive Behavior; Inappropriat

1998

Other Studies

7 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Panic Disorder

ArticleYear
Substance-induced anxiety disorder after one dose of 3,4-methylenedioxymethamphetamine: a case report.
    Journal of medical case reports, 2018, May-25, Volume: 12, Issue:1

    Topics: Adult; Anxiety Disorders; Behavior Therapy; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxy

2018
Persistent neuropsychological problems after 7 years of abstinence from recreational Ecstasy (MDMA): a case study.
    Psychological reports, 2004, Volume: 95, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Adult; Depressive Disorder; Erectile Dysfunction; Follow-Up Studies; H

2004
Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')
    The British journal of psychiatry : the journal of mental science, 1994, Volume: 165, Issue:3

    Topics: Adolescent; Adult; Cross-Sectional Studies; Delusions; England; Female; Hallucinations; Humans; Inci

1994
Panic disorder induced by large doses of 3,4-methylenedioxymethamphetamine resolved by paroxetine.
    Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:1

    Topics: Adult; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Panic Disorder; Paroxeti

1998
[Ecstasy and social pension: lost for life at 20 years of age?--Behavioral therapy of an anxiety disorder].
    Psychiatrische Praxis, 1998, Volume: 25, Issue:3

    Topics: Adult; Agoraphobia; Behavior Therapy; Combined Modality Therapy; Disability Evaluation; Female; Foll

1998
MDMA (Ecstasy) precipitation of panic disorder.
    Biological psychiatry, 1992, Jul-01, Volume: 32, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Agoraphobia; Alcohol Drinking; Amitriptyline; Arousal; Fluvoxa

1992
MDMA ("ecstasy") and panic disorder: induction by a single dose.
    Biological psychiatry, 1992, Nov-15, Volume: 32, Issue:10

    Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adult; Alprazolam; Anxiety Disorders; Arousal;

1992